Reported Earlier, TFF Pharmaceuticals Prices $4.8M Public Offering Of 1,665,219 Shares And Warrants At $2.875/Share Accompanying Warrant
Reported Earlier, TFF Pharmaceuticals Prices $4.8M Public Offering Of 1,665,219 Shares And Warrants At $2.875/Share Accompanying Warrant
TFF Pharmaceuticals announced the pricing of a public offering of an aggregate of 1,665,219 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 1,665,219 shares of common stock at a combined public offering price of $2.875 per share (or per common stock equivalent in lieu thereof) and accompanying warrant. The warrants will have an exercise price of $2.75 per share, will be exercisable immediately upon issuance and will expire five years from the date of issuance. The closing of the offering is expected to occur on or about May 1, 2024, subject to the satisfaction of customary closing conditions
TFF Pharmicals宣佈公開發行總計1,665,219股普通股（或代替普通股等價物）和認股權證的定價，以每股2.875美元（或以每股普通股等價物代替）和附帶的認股權證，購買最多1,665,219股普通股。認股權證的行使價爲每股2.75美元，將在發行後立即行使，並將自發行之日起五年內到期。此次發行預計將於2024年5月1日左右結束，但須滿足慣例成交條件
譯文內容由第三人軟體翻譯。